| "A Multinational, Open Label, Randomized, Active-controlled, 3-arm Parallel Group, 24-week Study Comparing the Combination of Glimepiride and Metformin Versus Glimepiride and Metformin Alone in Patients With Type 2 Diabetes " |
Terminated |
GLIMEPIRIDE-HOE490 |
3 |
GLIME_R_05809 |
King Fahad Specialist Hospital (Dammam), King Fahad Medical City (Riyadh) |
| SPIMACO Biosimilar Insulin Phase III Study: Clinical Efficacy and Safety |
Terminated |
Fastulin R / Normulin N |
3 |
(version 1.4) Aug 2011 |
King Fahad Medical City (Riyadh) |
| A Randomized Study of the Effect of Maintenance Therapy With Bevacizumab + Capecitabine Versus Bevacizumab Alone on Progression-free Survival in Patients With HER2-negative Metastatic Breast Cancer That Has Not Progressed During First-line Docetaxel Plus Bevacizumab Therapy |
Terminated |
Bevacizumab+ Capecitabine |
3 |
MO22223 |
King Abdulaziz Hospital and Oncology Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam) |
| Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure. A Randomised Double-blind Placebo-controlled International Multicenter Study. |
Terminated |
Ivabradine |
3 |
CL3-16257-083 |
King Fahad Medical City (Riyadh) |
| An open-Label, multicenter, expanded access study of Everolimus in Patients with advanced Nerouendocrine tumors. |
Completed |
Everolimus |
3b |
CRAD001K24133 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Phase 3b, open-labeled, randomized, parallel-group, multi-center study to evaluate the safety of novartis MenACWY Conjugate Vaccine when administered with routine infant Vaccinations to healthy Infants |
Completed |
Meningococcal ACWY Conjugate Vaccine |
3b |
V59P23 |
King Fahad Medical City (Riyadh) |
| Extending molecular responeses with Nilotinib in newly diagnosed chronic myeloid leukemia (CML) patients in chronic phase (ENESTxtnd) |
Completed |
Nilotinib |
3b |
CAMN107E2401 |
King Fahad Specialist Hospital (Dammam), King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Abdulaziz Medical City NG (Jeddah), King Abdulaziz Hospital and Oncology Center (Jeddah) |
| An Open-lable, Randomized, Multi center, Phase III Study to Compare the Saftey and Efficacy of TKI258 Versus Sorafenib in Patients with Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor Therapies" |
Completed |
TKI258 / Sorafenib |
3 |
CTKI258A2302 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Multicentre, Double-blind, Randomized, Placebo Controlled, Parallel Group, Phase 3, Safety Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma (DESTINATION) |
Ongoing |
Tezepelumab |
3 |
D5180C00018 |
King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh) |
| Comparison of the Efficacy and Safety for different regimen of Venous Thromboembolism pharmacoprophylaxis among Severely Burn Patients: A Multicenter, Randomized Controlled Trial |
Ongoing |
HEPARIN SODIUM, ENOXAPARIN SODIUM |
4 |
RC18/400/R |
King Abdulaziz Medical City NG (Riyadh) |
